Skip to main content

Advertisement

Log in

Mitochondrial DNA polymorphisms in pathologically proven Parkinson’s disease

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

To date, five single base pair changes of the mitochondrial DNA have been reported to occur either exclusively or with increased frequency in Caucasian patients with Parkinson’s disease (PD) and it has been postulated that these mutations might be causally related to the observed inhibition of mitochondrial respiratory chain function in PD. To evaluate these findings, we analysed the frequency of all five polymorphisms in 100 cases of pathologi cally proven cases of PD. We were either unable to detect the previously described polymorphisms in our series or found them to be present with the same frequency among controls. Our data do not support the hypothesis of an involvement of the mitochondrial DNA in the pathogenesis of PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bandmann O, Marsden CD, Wood NW (1996) The mitochondrial polymorphisms at bp 4336 and bp 5460 in pathologically proven Parkinson’s disease (abstract). J Neurol 43 [Suppl 2]:S7

    Google Scholar 

  2. Bennecke R, Struemper P. Weiss H (1993) Electron transfer complexes I and IV of platelets are abnormal in Parkinson’s disease but normal in Parkinson-plus syndromes. Brain 116: 1451–1463

    Article  Google Scholar 

  3. Checcarelli N, Prelle A, Moggio M, Comi G, Bresolin N, Papadimitriou A, et al (1994) Multiple deletions of mitochondrial DNA in sporadic and atypical cases of encephalomyopathy. J Neurol Sci 123:74–79

    Article  CAS  Google Scholar 

  4. Golbe LI, Di Iorio G, Bonavita V, Miller DC, Duvoisin RC (1990) A large kindred with autosomal dominant Parkinson’s disease. Ann Neurol 27: 276–282

    Article  CAS  Google Scholar 

  5. Haas R, Nasirian F, Nakano K, Ward D, Pay M, Hill R, et al (1995) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson’s disease. Ann Neurol 37:714–722

    Article  CAS  Google Scholar 

  6. Harding AE (1991) Neurological disease and mitochondrial genes. Trends Neurosci 14:132–137

    Article  CAS  Google Scholar 

  7. Holt IJ, Harding AE, Petty RKH, Morgan-Hughes JA (1990) A new mitochondrial disease associated with mitochondrial heteroplasmy. Am J Hum Genet 46:428–433

    CAS  PubMed  PubMed Central  Google Scholar 

  8. Hughes A, Daniel S, Kilford L, Lees A (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study. J Neurol Neurosurg Psychiatry 55:181–184

    Article  CAS  Google Scholar 

  9. Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 92: 6892–6895

    Article  CAS  Google Scholar 

  10. Janetzki B, Schmid C, Bischof F, Frölich F, Gsell W, Kalaria R, et al (1996) Investigations on the point mutations at nt5460 of the mtDNA in different neurodegenerative and neuromuscular diseases. Eur Neurol 36: 149–153

    Article  Google Scholar 

  11. Jun A, Brown M, Wallace D (1994) A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber’s hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 91: 6206–6210

    Article  CAS  Google Scholar 

  12. Kösel S, Lücking CB, Egensberger R, Mehraein P, Graeber MB (1996) Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 44:174–183

    Article  Google Scholar 

  13. Lazzarini A, Myers R, Zimmermann T, Mark M, Golbe L, Sage J, et al (1994) A clinical genetic study of Parkinson’s disease: evidence for dominant transmission. Neurology 44:499–506

    Article  CAS  Google Scholar 

  14. Lestienne P, Nelson I, Riederer P, Jellinger K, Reichmann H (1990) Normal mitochondrial genome in brain from patients with Parkinson’s disease and complex I defects. J Neurochem 55:1810–1812

    Article  CAS  Google Scholar 

  15. Mann VM, Cooper JM, Schapira AHV (1992) Quantitation of a mitochondrial DNA deletion in Parkinson’s disease. FEBS Lett 299:218–222

    Article  CAS  Google Scholar 

  16. Maraganore D, Harding AE, Marsden CD (1991) A clinical and genetic study of familial Parkinson’s disease. Mov Disord 6:205–211

    Article  CAS  Google Scholar 

  17. Markopoulou K, Wszolek ZK, Pfeiffer RF (1995) A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38:373–378

    Article  CAS  Google Scholar 

  18. Mizuno Y, Sone N, Saitoh T (1986) Dopaminergic neurotoxins, MPTP and MPP+, inhibit mitochondrial NADH-ubiquinone oxidoreductase activity. Proc Jpn Acad (Ser b) 62:261–263

    Article  CAS  Google Scholar 

  19. Nelson I, Hanna MG, Alsanjari N, Scaravilli F, Morgan-Hughes JA, Harding AE (1995) A new mitochondrial DNA mutation associated with progressive dementia and chorea: a clinical, pathological and molecular genetic study. Ann Neurol 37:400–403

    Article  CAS  Google Scholar 

  20. Ozawa T, Tanaka M, Ino H, Ohno K, Sano T, Wada Y, et al. (1991) Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalopathies and with Parkinson’s disease. Biochem Biophys Res Commun 176:938–946

    Article  CAS  Google Scholar 

  21. Petty R, Harding AE, Morgan-Hughes J (1986) The clinical features of mitochondrial myopathy. Brain 109:915–938

    Article  Google Scholar 

  22. Sandy MS, Langsten JM, Smith MT, Di Monte DA (1993) PCR analysis of platelet mtDNA: lack of specific changes in Parkinson’s disease. Mov Disord 8:74–82

    Article  CAS  Google Scholar 

  23. Schapira A, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD (1989) Mitochondrial complex I deficiency in Parkinson’s disease. Lancet I:1269

    Article  Google Scholar 

  24. Schapira A, Holt I, Sweeney M, Harding AE, Jenner P, Marsden CD (1990) Mitochondrial DNA analysis in Parkinson’s disease. Mov Disord 5:294–297

    Article  CAS  Google Scholar 

  25. Seidler A, Hellenbrand W, Robra B-P, Vieregge P, Nischan P, Joerg J, et al (1996) Possible enviromental, occupational and other etiologic factors for Parkinson’s disease: a case control study in Germany. Neurology 46: 1275–1284

    Article  CAS  Google Scholar 

  26. Shoffner J, Brown M, Torroni A, Lott M, Cabell M, Mirra S, et al (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17:171–184

    Article  CAS  Google Scholar 

  27. Smith P, Cooper J, Govan G, Harding A, Schapira A (1993) Smoking and mitochondrial function: a model for enviromental toxins. Q J Med 86:657–660

    Article  CAS  Google Scholar 

  28. Truong D, Harding AE, Scaravilli F, Smith S, Morgan-Hughes J, Marsden CD (1990) Movement disorders in mitochondrial myopathies. Mov Disord 5: 109–117

    Article  CAS  Google Scholar 

  29. Wallace DC (1995) Mitochondrial DNA variation in human evolution, degenerative disease, and aging. Am J Hum Genet 57:201–223

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Wszolek ZK, Cordes M, Calne DB, Münter MD, Cordes I, Pfeifer RF (1993) Hereditärer Morbus Parkinson: Bericht über drei Familien mit autosomal-dominantem Erbgang. Nervenarzt 64:331–335

    CAS  PubMed  Google Scholar 

  31. Zhang Y, Marcillat O, Giulivi C, Ernster L, Davies JA (1990) The oxidative inactivation of mitochondrial electron transport chain components and AT-Pase. J Biol Chem 265:16330–16336

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was presented in part at the sixth meeting of the European Neurological Society in The Hague [1]

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bandmann, O., Sweeney, M.G., Daniel, S.E. et al. Mitochondrial DNA polymorphisms in pathologically proven Parkinson’s disease. J Neurol 244, 262–265 (1997). https://doi.org/10.1007/s004150050082

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s004150050082

Key words

Navigation